GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Archived. This submission is more than a year old. Votes and new comments are closed, and some of the advice in it may have been superseded — check the community wiki for the current version.
536
c/glp1uk·posted 1 year ago by u/camila_sandvik

unpopular opinion: most of what gets said here about MHRA is guesswork

Discussion Well Actually ×8

Posting this as a discussion rather than a claim: unpopular opinion: most of what gets said here about MHRA is guesswork.

Discharged at goal back to the GP, who would not continue it. Nobody had mentioned that this was how it ends.

GP said no in the spring, specialist said yes eighteen months later. Same person, same numbers.

Four pharmacies, four prices, same product, same month. The spread was larger than I expected and none of them were the headline offer.

Happy to answer the boring questions. Those are usually the ones worth asking.

834 up / 298 down74% upvoted30 commentsid 7x81y38 May 2025

30 comments

25 in this archive, depth 5

best — the order this archive was captured in

u/viktor_kirchner85 points·1 year ago

Supply notices from the regulator describe expected availability at a national level. They do not predict what any individual pharmacy has on the shelf next week.

replysharereportpermalink
[deleted]63 points·1 year ago

[deleted]

replysharereportpermalink
u/rina_nascimento37 points·1 year ago

Same. My ICB threshold was different from the neighbouring one and nobody could tell me why.

replysharereportpermalink
u/emil_okwuosa13 points·1 year ago

A private prescription is an independent route: it does not affect NHS list position, and it is not a step in the same pathway.

replysharereportpermalink
u/marit_coelho4 points·1 year ago

Discharge from a specialist service at goal is a normal end point of that pathway. Whether prescribing continues in primary care afterwards is a local decision and is worth asking about at the start rather than at the end.

replysharereportpermalink
u/marit_mensa46 points·1 year ago

England, Scotland, Wales and Northern Ireland are four different pathways

replysharereportpermalink
u/ipamorelin_i15 points·1 year ago

the Irish scheme cap is the single most useful fact in this board

replysharereportpermalink
u/elise_ramos41 points·1 year ago

Yes — the consultation that asks nothing tells you what kind of service it is.

replysharereportpermalink
u/ilias_nakamura28 points·1 year ago

Small fix — that is the Scottish pathway. The post is asking about England and the answer is different.

replysharereportpermalink
u/lina_almeida33 points·1 year ago

Agreed on keeping letters. Dates are what make an appeal or a re-referral possible.

replysharereportpermalink
u/cormac_erdogan21 points·1 year ago

Push back: a private prescription is a separate route, not a shortcut through the NHS queue.

replysharereportpermalink
u/camila_sandvikOP-32 points·1 year ago

Yes — the consultation that asks nothing tells you what kind of service it is.

Agreed — and keeping the letters with dates is what makes any later challenge possible.

replysharereportpermalink
u/emeka_beaulieu1 point·1 year ago·edited

Agreed — and keeping the letters with dates is what makes any later challenge possible.

Disagreeing with this line: that is the arrangement in one nation and the question is about another.

replysharereportpermalink
u/curious_panel_only1 point·1 year ago

Agreed. The ICB variation is the thing that makes national advice useless here.

replysharereportpermalink
u/not_my_main_nm0 points·1 year ago

Yes — the consultation that asks nothing tells you what kind of service it is.

elise_ramos is right that the two routes are separate. A private prescription does not move you up the list.

replysharereportpermalink
u/emil_marchand39 points·1 year ago

Two years and four months on a tier 3 list. Referral date and every letter kept, which turned out to matter when the service reorganised.

replysharereportpermalink
u/camila_sandvikOP0 points·1 year ago

That is the first-month offer price, not the ongoing monthly cost. The tracker records the second one.

replysharereportpermalink
load more comments (4) →
u/boots_or_bustMOD21 points·1 year ago

Left up. It names a nation and an ICB, which is all we ask of a pathway post.

replysharereportpermalink
u/marit_mensa14 points·1 year ago

Correction: that threshold is your ICB’s, not a national one. They differ and they change by year.

replysharereportpermalink
u/lane_watchermod · logistics13 points·1 year ago

Careful, that pricing figure is a headline offer with conditions attached rather than the actual monthly cost.

replysharereportpermalink
u/chidi_abubakar8 points·1 year ago

Careful, that pricing figure is a headline offer with conditions attached rather than the actual monthly cost.

Adding the practical bit — ask what happens at discharge before you start, not after.

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/glp1uk

UK-specific access: NHS tier-3 and specialist weight-management pathways, the two-year waiting-list reality, private prescription routes and their monthly cost, pharmacy stock, MHRA supply notices, and how the UK rules differ from the US conversation that dominates most of the internet.

43kmembers
95submissions
Jan 2024created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.com
Sponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
c/glp1uk rules
  1. No naming online pharmacies that prescribe without a consultation.
  2. Price posts need the date — UK private pricing moves monthly.
  3. NHS pathway questions: say which nation. England, Scotland, Wales and NI differ.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.